Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-controlled, Single-Ascending-Dose and Multiple-Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RNV-166 in Healthy Male Volunteers

NCT07809360 is registered in ClinicalTrials.gov with InVitro Research Solutions Private Limited as lead sponsor.

NCT NCT07809360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07809360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-controlled, Single-Ascending-Dose and Multiple-Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RNV-166 in Healthy Male Volunteers
Lead sponsor
InVitro Research Solutions Private Limited
Phase
Phase 1
Overall status
Completed
Start date
August 22, 2024
Completion date
February 5, 2025
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

first in man study to evaluate initial safety